High materiality8/10
Veracyte assumed with a Buy at UBS
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS upgrades Veracyte (VCYT) with a Buy target of 65; current price 42.45; priceChangeSinceSignal +3.32, indicating positive momentum.
- UBS target raised to 65; price 42.45; momentum +3.32
Key facts
- 01
Target: $65
- 02
Posted price: $42.45
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.